Home News Long-term dupilumab treatment of OCS-dependent asthma reduced OCS use back to News
minute read
Long-term treatment with dupilumab helped patients with oral corticosteroid-dependent asthma wean their oral corticosteroid use and also reduced exacerbations and improved lung function.
Topics: Press Coverage
13001 East 17th Place
Aurora, CO 80045
303.724.5375
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
